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ABSTRACT 
GO FOR A WALK! MONITORING WALKING FOR DEPRESSED MOOD 
By 
Michael Edwin Shrake 
 Literature suggests that exercise has benefits for health and mood.  For people 
suffering from depression however, even summoning motivation to go for a walk can 
seem impossible, no matter the alleged benefits.  My study builds on current articles 
suggesting that wearable technology like activity-tracking bracelets can have significant 
effects on motivation and physical health goals.  The current study followed 11 
individuals who met the minimum threshold for depression as measured by the Patient 
Health Questionnaire-9 (PHQ-9) for a period of 28 days and tracked their walking using a 
Jawbone UP activity bracelet.  The results showed that daily activity differed 
significantly across participants and did not have an effect on daily scores on PHQ-9 
questions except for the Question 5 related to appetite. These scores increased 
significantly at the end of the period (day 27 specifically) but also decrease significantly 
the following day (day 28) suggesting that appetite concerns fluctuate day to day and do 
not necessarily correlate with the number of steps.  Concerns about sleep were less 
intense on average during the first week but fluctuated across the remaining three weeks. 
Scores indicating whether participants felt bad about themselves varied between high and 
low scores over the period and had no correlation with the number of steps.   
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INTRODUCTION 
 
 
 
 
This study is concerned with how monitoring physical activity affects mood on a 
day-to-day basis.  Literature on depression suggests that exercise may reduce symptom 
severity for depression (Aurelio et al. 2005, Dixon et al. 2003, Luppino et al. 2010, 
Lepine & Briley 2011) and that activity trackers can improve motivation.  First, the daily 
relationship between specific depression symptoms and physical activity such as walking 
is non-existent. Second, to my knowledge no study has tried to monitor daily walking 
activity with same-day specific symptom severity for depressed people. My thesis 
explores, to some extent, the relationship between daily walking and depression 
symptoms using the Patient Health Questionnaire for depression, also known as the PHQ-
9 and an activity tracker bracelet (UP™ by Jawbone). 
In this work, daily walking was defined as the number of steps the participant 
takes per day and was recorded using the bracelet for a duration of 28 days; while over 
the same period the participants were asked to complete a modified PHQ-9 on a daily 
basis. 
The original PHQ-9 was designed to be taken every two-weeks but it can also be 
adapted for shorter periods such as in a study by Torous et al (2015), where participants’ 
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daily mood was collected every day through texting. Another study showed that daily 
ratings can be used to illustrate a more detailed picture of the depression profile of an 
individual compared to the traditional instructions of the PHQ-9, where the daily high 
and low intensity of symptoms are averaged into a single score across the previous two 
weeks (Aguilera et al, 2015).  Aguilera et al (2015) suggested that asking an individual to 
recall symptom frequency over the previous two weeks may be subject to a recency bias. 
In our case, we slightly modify the questionnaire by asking the participants to report their 
symptoms on a daily basis rather than over a two week period.   
 Chapter 1 is an overview of modern depression and the effect of walking on 
depression.  This chapter starts with a discussion of differences in the defining features of 
depression between the earliest diagnostic manuals and the most current.  It also 
discusses the development and the use of depression screening inventories along with 
differences in the frequency of diagnosis between genders.  The following section 
focuses on walking as a treatment for mild depression.  It begins with a discussion of 
common depression interventions such as cognitive behavioral therapy and psychiatric 
medication.  Walking is proposed as an intervention for mild depression, which does not 
require the higher level of care provided by a therapist or psychiatrist.  Literature 
examining the effect of exercise on mood is discussed, followed by a handful of studies 
that utilized pedometers and health surveys to track changes in physical and emotional 
wellness, as well as the tracking devices’ effect on motivation. 
Chapter 2 goes over the study itself and our results.  We selected a depression 
screening inventory (the PHQ-9) and utilized it to screen potential participants for a 
minimum threshold of depression.  Participants in our sample received an activity 
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tracking bracelet and then completed a PHQ-9 modified for daily use for 28 days.  Data 
were analyzed using a Linear Mixed Model in SPSS.  We found that the number of days 
wearing the tracker bracelet had a significant effect on the variance of PHQ-9 questions 
across participants but no significant effect on the scores of PHQ-9 over time except for 
question 5 which is related to eating too much or too little.  Finally, while our study did 
not find an effect for Day of participation on the number of steps, correlating the number 
of daily steps to the day’s PHQ-9 sum score produced a negative correlation for eight of 
eleven participants. 
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CHAPTER ONE: MODERN DEPRESSION 
1. DEPRESSION 
 Depression is a common mood disorder found worldwide across age, gender, and 
demographic (Robertson et al, 2012).  It effects professional, social, and emotional 
interaction including work productivity, intimate relationships, and daily moods.  
Symptoms typically include sadness, apathy, and a feeling of emotional isolation or 
detachment (Bostwick & Pankratz, 2000).  Though an average depressive episode lasts 
between three and six months, depression can be recurrent and a lifetime struggle (Lepine 
& Briley 2011). 
Diagnostic criteria for depression have evolved over time and are regularly revised 
with new editions of diagnostic manuals such as the Diagnostic and Statistical Manual of 
Mental Disorders (DSM) and the International Statistical Classification of Diseases and 
Related Health Problems (ICD).  With progressive editions of the DSM, the lifetime 
prevalence of depression had increased from 3% of the population in 1970 (with the 
DSM-II) to 10-20% in 1994 (with the DSM-IV) (Bostwick & Pankratz, 2000).  It is 
important to note that different definitions of depression, particularly between editions of 
diagnostic manuals, which emphasized or omitted different symptoms, contributed to the 
ballooned rates of prevalence.  The DSM-II defined “Manic-depressive illness, depressed 
type” as a disorder characterized by severely depressed mood and mental and motor 
retardation (American Psychiatric Association, 1975).  Additional symptoms could 
include uneasiness, apprehension, perplexity, and agitation.  Manic-depressive illness, 
depressed type differed from manic or circular types in that it consisted exclusively of 
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depressed episodes (American Psychiatric Association, 1975).  By contrast, the DSM-IV-
TR features seven mood disorder diagnoses where depression can be the primary 
symptom, including two diagnoses that classify the depression diagnosis either as an 
episode or a disorder (major depressive episode/disorder and bipolar episode/disorder)  
(American Psychiatric Association, 2000).  The DSM 5 elaborates further, distinguishing 
eight distinct diagnoses in the section “Depressive Disorders”, spanning 33 pages; a 
significant elaboration from the page and a half of the DSM-II (American Psychiatric 
Association, 1975, 2013)! 
 The DSM 5 includes:  Disruptive Mood Disregulation Disorder; Major 
Depressive Disorder; Persistent Depressive Disorder (Dysthymia); Premenstrual 
Dysphoric Disorder; Substance/Medication-Induced Depressive Disorder; Depressive 
Disorder Due to Another Medical Condition; Other Specified Depressive Disorder; and 
Unspecified Depressive Disorder.  Each of these diagnoses is characterized by a sad, 
empty or irritable mood along with significant somatic and cognitive changes, which 
impair the individual’s capacity to function.  They differ in duration, timing, and 
presumed etiology (See Appendix B for more detailed definition of each disorder). 
1.1. ASSESSING DEPRESSION 
 To assess depression several tests and scales have been developed following DSM 
criteria.  These include the Beck Depression Inventory – II (BDI-II) (Beck, Steer, & 
Brown, 1996) and the PHQ-9 (Kroenke et al., 2001).  The BDI-II is a revision of the 
widely used Beck Depression Inventory (BDI), introduced in 1961 as a 21-question 
survey designed to measure the behavioral manifestations of depression (Beck et al, 
1996, Beck et al, 1961).  A new edition of the BDI-II was released 35 years later in 1996 
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in response to incremental changes in symptoms defining depression, including revisions 
in the DSM.  It is used to identify specific depression symptoms and their frequency for 
psychiatrically diagnosed adults and adolescents, but it is not used as a lone diagnostic 
tool, as symptoms of depression may be part of a separate primary disorder (Beck et al, 
1996).  The Patient Health Questionnaire (PHQ-9) is a nine-item survey used to screen 
for depression and symptom severity (Lowe et al. 2003).  It was developed by Pfizer in 
the early 1990’s as part of PRIME-MD, an instrument used to assist clinicians in making 
criteria-based diagnosis of five DSM-IV disorders commonly encountered in medical 
patients (Kroenke & Spitzer, 2002).  Kroenke et al. (2001) found it was well-validated in 
fifteen studies including over 6,000 patients.  Because it is entirely self-administered and 
brief, the PHQ-9 is now the most commonly used depression screening tool in clinical 
and research settings (Malpas et al. 2010; Lowe et al. 2003; Kroenke & Spitzer 2002). 
The PHQ-9 assesses an individual’s depression symptoms over two weeks, since 
according to the DSM-IV, “a symptom must be present for at least two weeks to be 
included in a diagnosis of depression.”  For research purposes, to evaluate the effect of a 
specific factor such as walking in our case, it is possible to modify the PHQ-9 for daily 
ratings as they reflect the mood more closely (Aguilera et al., 2015).  Korenke et al. 
(2001) report that PHQ-9 scores of 5, 10, 15, and 20 represent the lowest thresholds for 
mild, moderate, moderately severe, and severe depression respectively. 
1.2. GENDER DIFFERENCE 
Women are approximately 1.7 times more likely than men to report a lifetime 
history of depression but do not differ in the overall course of depression nor the 
7 
 
likelihood of a recurrence in the subsequent twelve months (Kessler et al., 1993, Nolen-
Hoeksema, 1991). 
 There is also no significant difference in the average age of the depression onset 
between men and women (24.04 years old and 23.53 years old respectively) (Kessler et 
al, 1993). Nolen-Hoeksema (1987) found that, with few exceptions, women report more 
depressive symptoms than men worldwide. The researcher evaluated possible differences 
in relations between several psychosocial, economic, and biological factors between the 
two genders but none of them was significant. The researcher suggested that this 
difference could be related to their responses to stress and engagement in distractive 
behaviors, as females tend to report ruminative behaviors with lower levels of general 
activity, while males generally pursue distractions from stress including physical activity 
(Nolen-Hoeksema, 1987). The physical activity engagement and relationship to mood is 
explored in depth in the following section. 
In a different study, Nolen-Hoeksema & Girgus (1994) suggested that ruminative-
style responses were related to higher depression scores for both genders.  One proposed 
explanation by Nolen-Hoeksema (2003) is that rumination on negative emotions, even 
with the intention of problem solving, can draw the individual into negative cycles of 
thinking which in turn reduces the quality of proposed solutions.  Whether rumination is 
a self-reflective style focused on solutions or a brooding style focused on negativity is 
specifically related to variations in levels of depression for women, where rumination 
with brooding traits correlated with elevated levels of depression.  Though females were 
significantly more likely to demonstrate ruminative responses than males, both genders 
exhibited higher rates of depression with ruminative responses in general than other types 
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of response and it is suggested that response style may be more indicative of 
susceptibility to depression than gender alone (Nolen-Hoeksema & Girgus 1994, Nolen-
Hoeksema 2003).  However, gender may influence which response styles an individual 
develops.   
Differences in typical response style is proposed to be a product of social 
reinforcement: men are praised or belittled for emotional responses based on social 
concepts of masculinity (“act like a man”); while emotional responses in girls receive less 
attention, whether positive or negative, compared to boys; which could lead to learned 
helplessness and a greater likelihood of depression (Nolen-Hoeksema, 1991).  Children 
of either gender may develop a ruminative or passive response to negative affect if their 
parents/caregivers model a ruminative response style at home.  This response style may 
also develop if the child is not exposed to appropriate adaptive responses, which may 
include benign distraction or appropriate problem solving (Nolen-Hoeksema, 1991).  It 
has been suggested that depressed people with ruminative response styles may recover 
after learning to control the ruminative response through distraction during the course of 
CBT (Nolen-Hoeksema, 1991).   
2. WALKING AS A TREATMENT FOR DEPRESSION 
As mentioned previously, engaging in physical activity is considered a distractive 
behavior and therefore could be related to less depressive mood (Nolen-Hoeksema, 1987, 
Nolen-Hoeksema, 1991). Modern treatment of depression typically includes cognitive 
behavioral therapy (CBT) and/or prescription medication.  Vernmark et al (2010) report 
that several psychological interventions have shown relatively similar outcome effects for 
depression from CBT, online CBT, and prescription medication.  Cognitive behavioral 
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therapy consists of identifying and modifying faulty thought processes, attitudes, and 
behaviors, and is often paired with psychopharmacological treatments (Durand 2010, 
Butler et al., 2006).  Robertson et al. (2012) stated that treatment with antidepressants is 
not recommended for people with mild depression and suggested that physical activity 
should be evaluated for therapeutic use with depressed patients because it might alleviate 
depression. 
 Other studies have demonstrated that there is a relationship between activity level 
and mood (Aurelio et al. 2005, Dixon et al. 2003, Luppino et al. 2010, Lepine & Briley 
2011).  Some researchers have found evidence to support the activity of walking as a 
treatment for depression, though their experiment did not examine which specific 
symptoms were effected, reporting only whether symptoms in general improved, stayed 
the same, or got worse over the course of the study (Mobily et al. 1996).  Though this 
study focused on elderly rural adults, it found that even light-intensity exercise such as 
walking had a positive correlation with the reduction of depressive symptoms.  Changes 
in exercise behavior were predictive of depressive symptoms at a follow-up three years 
later, while overall the data suggest that this daily level of exercise can reduce depressive 
symptoms at mild, moderate, and severe levels of depression.  Another researcher 
proposed that physical activity functions as a distraction to negative moods, particularly 
in depression, by diverting attention to a task and preventing rumination (Nolen-
Hoeksema, 1987). 
 An additional benefit of light exercise (such as walking) while treating depression 
is that it is a viable option for most people, even those who may be geographically or 
financially unable to spend time with a therapist.  As reduced energy and activity is a 
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common symptom of depression and could rationally impede light daily exercise, we 
sought a motivational component to possibly enhance the number of steps a person might 
take in a day (Salmon, 2001). 
3. FITNESS TRACKERS AND THEIR EFFECT ON MOTIVATION 
There have been a handful of recent studies examining the effectiveness of fitness 
trackers on motivating less-active people to become more active.  The use of pedometers 
has helped adults and seniors to improve health by significantly lowering blood pressure, 
body mass index (BMI), and achieve daily step targets (Klein, 2015).  Wearable 
technology such as activity bracelets are becoming more advanced by the year and their 
accuracy in monitoring numbers of steps taken, duration and quality of sleep, and other 
biometrics ought to be regularly applied to new research in a variety of intersectional 
studies (Paul et al., 2015, Attick, J. et al., 2016).  Beyond personal use, wearable 
technology could help physicians monitor patients remotely between visits, which itself 
could be helpful for rural or elderly populations (Attick, J. et al. 2016). 
A community study in Scotland found that participants who were given a pedometer 
for twelve weeks and completed daily reports on step counts and health outcomes 
significantly increased their step count (p < .001), time spent in leisure walking, and 
positive mood compared to a control group (Baker et al. 2008).  The researchers 
cautioned that the health consultation about the benefits of walking in their study has 
previously been shown to increase daily activity by itself, though no significant effect for 
the consultation alone increased daily walking in their study.  A meta-analysis found a 
significant effect for motivation on the number of steps with pedometers when 
participants recorded their activity by hand on a monthly calendar (Tudor-Locke and 
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Lutes, 2009).  Participants who manually recorded their numbers each day reported a 
mean daily step increase of 2000 steps per day over baseline, while those who wore the 
pedometer without recording their steps increased daily step count by a mean of 832 
steps.  Participants in the study explained that a tangible record of their steps worked as a 
motivator, particularly when comparing their current day steps to previous days. Since 
activity trackers help with the motivational levels of the person wearing it, we wondered 
whether their usage could enhance the motivational levels of people suffering from mild 
depression to engage more often in walking.  Measurements for motivation were inferred 
by an increase in daily number of steps across the month of participation. 
4. CONCLUSION 
The evaluation of symptom severity and its modulation with various daily walking totals 
creates a number of opportunities for research and therapeutic applications.  Walking is 
generally a safe, healthy, achievable goal for patients exhibiting a range of psychological 
maladies including depression.  The use of activity tracking devices including pedometers 
and bracelets has been shown to motivate a variety of populations to increase their daily 
step rate, resulting in numerous health benefits and often an increase in positive affect. 
The examination of the relationship between specific depression symptoms and the 
number of daily steps should provide groundwork for future investigations into the 
modulatory effects of daily activity upon symptoms of depression. 
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CHAPTER TWO: WALKING AS A POTENTIAL 
TREATMENT FOR DEPRESSION 
1. INTRODUCTION 
The purpose of this study is to explore the relationship between walking and depression 
scores for individuals who reported mild depression, and to investigate whether fitness 
trackers that monitor activity such as walking can motivate these individuals to keep up 
with their activity, demonstrated by an increase in the number of daily steps from the 
beginning of the study to the end.  Previous studies have examined the relationship 
between mood and various forms of exercise, but to our knowledge, no one correlated the 
total number of steps by day with daily depression scores for an extended period of time 
(twenty-eight days).  On one hand, we used walking specifically because 1) it does not 
require any cost, 2) it can be easily tracked (using a fitness bracelet), and 3) it was 
suggested as an intervention for mild to moderate depression in a study by Robertson et 
al. (2012).  On the other hand, with the emergence of activity trackers on the market that 
have been shown to enhance motivation, we would like to assess their motivational role 
when a person’s mood is down. 
2. METHODS 
2.1. PARTICIPANTS 
Participants were recruited from undergraduate Northern Michigan University courses in 
general psychology, statistics, and research methods.  Recruitment of students took place 
via email from professors to their respective class lists.  Students were informed in the 
email that there was a brief survey about emotion and that a larger study would be taking 
13 
 
place utilizing an activity tracking bracelet and brief nightly surveys.  Eleven students, 
nine females, participated in the full study after prescreening.  Participants ranged in age 
between 18 and 42 years (mean: 23.08 years, standard deviation: 6.63 years).  The mean 
baseline PHQ-9 score for selected participants was 13.58, with a standard deviation of 
5.53 and a range from 6 points to 25 points. 
2.2. STIMULI AND APPARATUS  
Participants were provided with a “Jawbone UP”™ health tracking bracelet for use 
through the duration of the study.  A study evaluating the accuracy of ten different 
activity trackers found this bracelet to be reliable when monitoring walking in laboratory 
and home settings with the mean absolute percentage error (-1.0, 1.4) respectively 
(Kooiman et al., 2015).   Data from the bracelets were collected weekly using iPads with 
the Jawbone app.  Data were processed using Excel and SPSS.  Participants were 
instructed to remove the bracelet only to charge once weekly at night and when bathing 
or swimming as it is not waterproof.    Participants received an email at 9:00 PM each 
evening with the modified PHQ-9 Survey. They were instructed to complete the survey at 
the end of each day. 
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2.3. PROCEDURE 
2.3.1. PRE-SCREENING:  
Volunteers were directed to a website (Qualtrics, Provo, UT) to complete a modified 
PHQ-9 survey (Appendix 1).  Three hundred and eighty eight volunteers completed the 
pre-screening survey across the course of the study, with the pre-screening offered at the 
beginning of each academic semester beginning with summer 2016.  Of one hundred and 
ninety participants who scored at least 5 points (the minimum threshold for mild 
depression) and higher, eighty indicated an interest in participating in the full study and 
were emailed an invitation to participate.  Participants were selected on a first-response 
basis.  The incentive for completing the screening survey was extra credit in class.  The 
incentive for completing the full 28 day study was a $20 gift card to Target. 
A final participation sample of eleven subjects were selected from all invited 
participants.  Screened individuals were instructed on the procedures of the study and 
provided their consent to participate in the study. Bracelets were to be worn around the 
clock except when charging or in the shower, and were worn on the participants’ arm of 
choice.  Data was not collected concerning the arm of preference for the participant.  The 
study was approved after review by the Institutional Review Board (IRB) of Northern 
Michigan University in February 2016 (approval code HS 16-761). 
2.3.2. EXPERIMENT 
Data recorded on the Jawbone bracelet began with the first full day the participant 
wore the bracelet.  Surveys were sent at 9:00 PM each evening to participants’ preferred 
email address beginning on the first full day of data collection.  Participants met with the 
researcher once a week to collect data from the wristbands in most cases.  If such a 
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meeting was missed, data were usually collected within a couple of days.  When the 
participant had completed 28 surveys with activity data for each day, participation was 
considered fulfilled, the bracelet was returned, and the participant received the promised 
$20 gift card.  Participants with five or more days of missing survey data did not receive 
the incentive. 
 The nightly survey for participants featured a PHQ-9 which was altered to inquire 
only about the previous 24 hours.  The survey also included four social questions 
inquiring as to what extent the participant interacted with close friends, interacted with 
family, spent time on leisure activities, and time spent idly during the day.  In this study 
the daily number of steps is a predictor variable while specific symptom severity is a 
criterion variable.  When evaluating motivation successive days is a predictor variable 
while the number of steps is the criterion variable. 
2.4. ANALYSIS 
Data were analyzed in SPSS using a Linear Mixed Model (LMM) with Days as a 
factor.  The LMM provides a better fit of the data over a repeated measured analysis for 
the same dataset since our data are considered longitudinal repeated measures. It can also 
handle missing point times in case participants forgot to fill in the PHQ-9 questions.  
Repeated measures LMMs were used as each participant’s questions were recorded 28 
times, with Participant (11) entered as a random effect (intercept), and Days (28) entered 
as a fixed effect. For each step, the significance of the fixed effect Days was assessed 
with Type III SS F-tests on the final multivariate model. Changes in model fit for fixed 
effects were assessed with maximum likelihood (ML) estimation. For all the questions, 
models were fitted using AR(1) (first-order autoregressive) and ARH(1) (heterogeneous 
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first-order autoregressive) that are more suited to longitudinal repeated measures (Field, 
2013). 
3. RESULTS: 
This study was designed to examine the relationship between monitoring physical 
activity and depression symptom severity for people experiencing mild depression.  The 
eleven participants (nine female) raged in age from 18-42, with a mean age of 23.  
Baseline scores on the PHQ-9 from our participants ranged from 6-25 points, with a 
mean score of about 13.5.  Across 308 individual surveys for the 11 participants, 30 were 
not completed.  
Motivation was monitored by the number of steps taken per day from Day 1 to Day 
28.  Daily symptom severity was measured using the PHQ-9 and each symptom was 
analyzed across participants by Day.  A daily depression severity sum score was 
correlated for each participant with the number of steps they took that same day. 
3.1. RESULTS: STEPS 
Figure 1 shows the number of steps against days for each participant.  Six of the 
eleven participants (P1, P5, P6, P7, P10, P11) showed a broad range of activity best 
depicted with a moving average.  Two participants (P2, P3) started their participation at 
or near their highest levels of recorded steps before quickly dropping away to reporting 
no steps at all.  P9 is similar to P2 and P3, but with more variance in the number of steps 
between days before ceasing to report number of steps.   
Participants P4 and P8 demonstrated general upward trends in number of steps 
taken by day.  P4 shows a logarithmic trend line, their rate of increase in steps per day 
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gradually slowing across days.  Participant P8 follows a gradual linear positive slope, 
increasing steps per day particularly in the final week of their participation.  Using the 
LMM, the relationship between days and steps showed significant variance in intercept 
across participants Var(u0j) = 4.98 x 10
13, 2(1) = 15.96, p < .01.  Each participant 
recorded significantly different numbers of steps at the beginning of the study, and their 
pattern of steps across days differed between each participant.  No two participants were 
alike in their daily number of steps. Days did not significantly affect the number of steps.  
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FIGURE 1. THE NUMBER OF STEPS PER DAY BY PARTICIPANT.  
3.2. RESULTS: PHQ-9 
3.2.1. PHQ-9: QUESTION1: 
Question 1 from the PHQ-9 deals with diminished interest or pleasure in doing 
things. It asked the participants: “Over the last 24 hours, have you experienced little 
interest or pleasure in doing things?” The relationship between days and PHQ-9-1 
showed significant variance in intercept across participants, Var(u0j) = .15, 2(1) = 24.5, p 
< .01. However, days did not significantly affect question 1 of the PHQ-9. 
3.2.2. PHQ-9: QUESTION2: 
Question 2 from the daily PHQ-9 asked participants: “Over the last 24 hours, have 
you experienced feeling down, depressed, or hopeless?”  The relationship between days 
and PHQ-9-2 showed significant variance in intercept across participants, Var(u0j) = .016, 
2(1) = 32.79, p < .01.  Question 2 of the PHQ-9 was not significantly affected by Days. 
3.2.3. PHQ-9: QUESTION3: 
Question 3 from the PHQ-9 enquires about sleep concerns.  Participants were asked: 
“Over the last 24 hours, have you experienced trouble falling or staying asleep, or 
sleeping too much?”  The relationship between days and PHQ9-3 showed significant 
variance in intercept across participants, Var(u0j) = .026, 2(1) = 46.62, p < .01.  Days h 
significantly affected question 3 scores of the PHQ-9 (p = 0.08). Figure 2 shows the mean 
scores per day for question 3.  It seems that participants’ sleep was improving during the 
first 10 days but start fluctuating for the rest of the testing period suggesting that wearing 
the bracelet did not affect the mood of the participants (see figure 2). More specifically 
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there was no significant correlation between the PHQ-9 scores for question 3 and the 
number of steps. 
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FIGURE 2. MEAN SCORES ACROSS PARTICIPANTS FOR THE THIRD QUESTION OF THE 
PHQ-9 BY DAY. 
3.2.4. PHQ-9: QUESTION4: 
Question 4 from the PHQ-9 covers fatigue and feelings of low energy.  It asked 
participants: “Over the last 24 hours, have you experienced feeling tired or having little 
energy?”  The relationship between days and PHQ-9-4 showed significant variance in 
intercept across participants, Var(u0j) = .036, 2(1) = 63.36, p < .01.  Days did not 
significantly affect question 4 of the PHQ-9. 
3.2.5. PHQ-9: QUESTION5: 
The PHQ-9’s fifth question deals with appetite, asking the participants: “Over the last 
24 hours, have you experienced poor appetite or over eating?”  The relationship between 
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days and PHQ-9-5 showed significant variance in intercept across participants, Var(u0j) = 
.028, 2(1) = 52.5, p < .01.  The variation in scores for question 5 of the PHQ-9 were 
significantly affected by Days F(27,159.46) = 2.32, p = .001. Pairwise comparisons with 
Bonferroni correction confirmed that question 5 for Day 27 differs from Day 5 (p = .004), 
Day 13 (p = .016), Day 24 (p = .005), and Day 28 (p = .011). Table 1 summarizes the 
mean and standard deviation of the scores for these questions. On Day 27, participants 
averaged a score just under 2 (moderately experiencing poor appetite or over eating) 
while scores for Days 5, 13, 24, and 28 are below .7 (between not at all experiencing poor 
appetite or over eating and lightly experiencing poor appetite or over eating, Table 1).  
Participants had more concern for food on Day 27 than any other days of interest.   
TABLE 1. MEANS AND STANDARD DEVIATION FOR QUESTION 5 OF THE PHQ-9 FOR 
DAYS 5, 13, 24, 27, AND 28 
DAY Mean (M) SD 
DAY 5 .64 .25 
DAY 13 .69 .26 
DAY 24 .82 .25 
DAY 27 1.88 .26 
DAY 28 .66 .28 
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3.2.6. PHQ-9: QUESTION6: 
Question 6 of the PHQ-9 focuses on feelings of failure and disappointment in oneself.  
Participants were asked: “Over the last 24 hours, have you experienced feeling bad about 
yourself – or that you are a failure or have let your family down?”  The relationship 
between days and PHQ-9-6 showed significant variance in intercept across participants, 
Var(u0j) = .023, 2(1) = 55.07, p < .01.  Question 6 of the PHQ-9 was almost significantly 
affected by Days (p = .09). As shown on Figure 3, it seems that participants’ concerns 
about disappointment and failures decrease over the first 13 days of the experiments but 
start changing quickly on a daily basis until the end of the experiment. Again, no 
correlation between the number of steps and the scores of question 6 were found for each 
participant. 
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FIGURE 3.  MEAN SCORES OF PHQ-9 QUESTION SIX BY DAY.   
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3.2.7. PHQ-9: QUESTION7: 
The seventh question of the PHQ-9 focuses on issues of concentration, asking the 
participants: “Over the last 24 hours, have you experienced trouble concentrating on 
things, such as reading the newspaper or watching television?”  The relationship between 
days and PHQ9-7 showed significant variance in intercept across participants, Var(u0j) = 
.025, 2(1) = 31.75, p < .01.  Days did not significantly affect question 7 of the PHQ-9. 
3.2.8. PHQ-9: QUESTION8: 
In question 8 of the PHQ-9, participants were asked: “Over the last 24 hours, have you 
experienced moving or speaking so slowly that other people could have noticed?  Or the 
opposite – being so fidgety or restless that you have been moving around a lot more than 
usual?”  The relationship between days and PHQ-9-8 showed significant variance in 
intercept across participants, Var(u0j) = .21, 2(1) = 42.17, p < .01.  Days did not 
significantly affect question 8 of the PHQ-9. 
3.2.9. PHQ-9: QUESTION9: 
Question 9 of the PHQ-9 concerns thoughts of wanting to hurt oneself.  The participant is 
asked: “Over the last 24 hours, have you experienced thoughts that you would be better 
off dead or hurting yourself in some way?”  The relationship between days and PHQ-9-9 
showed significant variance in intercept across participants, Var(u0j) = .09, 2(1) = 17.97, 
p < .01.  Days did not significantly affect question 9 of the PHQ-9 
3.3. RESULTS: STEPS AND PHQ-9 SUM SCORES 
Correlating the number of daily steps to the PHQ-9 sum score by day per participant 
produced a negative correlation for eight of eleven participants.  Two participants 
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achieved statistical significance for the correlation, p < .05.  Participant 2 achieved 
significance at p = .01, however their correlation only included five data points and 
should not be considered representative.  Table 2 summarizes the correlation coefficient, 
the coefficient of determination, and the significance value for each participant.  Blue 
cells denote a negative correlation.  Yellow highlights correlations which achieved 
significance. 
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Figure 4. The number of steps per day (X-axis) correlated with the sum symptom 
score for the daily PHQ-9 (Y-axis) by participant 
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Table 2. Correlation strength between number of steps and PHQ-9 sum scores 
 P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 
Pearson r -.11 .95 .06 -.25 -.45 -.39 -.46 .03 -.22 -.05 -.30 
R2  .01 .90 .00 .06 .20 .15 .21 .00 .05 .00 .09 
Significance >.05 =.01 >.05 >.05 =.05 >.05 =.04 >.05 >.05 >.05 >.05 
 
4. DISCUSSION 
The results shows that relationship between days and all PHQ-9 questions displayed 
significant variance in intercept across participants. This suggests depression symptoms 
vary day to day among individuals wearing activity-tracking bracelets. However, there 
were no significant variations in the question responses between the 28 days, except for 
question 5 of the PHQ-9 dealing with poor appetite and overeating. The mean scores 
increased significantly on day 27 and dropped significantly the following day. The 
question however is confusing for daily tracking, as we cannot really know whether 
scores increase for overeating or appetite loss, or a mix of both.  
Days had no significant effect (p = .08) on Question 3 of the PHQ-9 (sleep 
concerns), but again because the question deals with two opposing sleep issues, we are 
unable to determine the measure’s relationship with walking over this period as 
participants might be having trouble falling asleep one day and sleeping too much the 
following day. Although it is suitable for a bi-weekly screening, monitoring sleep on a 
daily basis requires a more precise question.   
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Question 6 scores of the PHQ-9 (Feeling bad about oneself, or as though they 
have failed their family) were not significant, and no correlation was found with the 
number of steps. 
There was no significant effect of Days on number of steps.  We did find a 
moderate negative correlation between the number of steps taken in a day for a 
participant and their daily sum score on the PHQ-9.  On days where participants reported 
a higher number of steps their PHQ-9 sum score was generally lower than it was on days 
where they took a lower number of steps. 
The Jawbone Up™ bracelet was used because it was the cheapest on the market, 
but had the drawback of including minimal features. It also required a USB connection 
via a phone or a tablet and could not provide any feedback to the participants. The Tudor-
Locke & Lutes (2009) study showed that individuals who wrote down their steps 
increased their daily activity, suggesting that self-monitoring was a greater motivating 
factor to increase activity than simply wearing an activity tracker. Although their study 
did not address depression, it is possible that use of more sophisticated bracelets with 
features that allow tracking and feedback would have been necessary to verify the initial 
hypothesis that walking can help with depression over time. 
An initial idea of the present was to develop a phone application intended to 
motivate depressed persons and help them complete their daily activities.  The 
application was to be a game where a digital avatar or “friend” would interact with the 
depressed person through the user’s phone or tablet device, proposing engaging 
challenges and offering encouragement based on the activity levels using a tracker. 
During the literature review however, studies evaluating the specific act of walking and 
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its effect on depression were scarce.  Different articles explored various types of exercise 
and their interaction with general mental and physical health.  A handful discussed 
walking and mood changes, but did not focus specifically on depressed persons and the 
correlation of their daily numbers of steps.  Other research focused on guided walking at 
various points in the week, but did not track participants’ walking outside of the sessions 
with the researchers.  The latter study’s neglect of that variable led to the current study. 
 This study recruited participants who exceeded a minimum threshold of 
depression on a screener PHQ-9; accordingly, it was likely that there could be some 
issues with data collection, such as missed nightly surveys, absent meet-ups to draw data 
from the bracelets, or even willingness to participate beyond the prescreening.  Weather 
functioned as a limitation in this study as most of our data were collected in the winter 
time where walking proves to be challenging or difficult.  Additional limitations included 
bracelets not being charged, resulting in participants wearing them for several days with 
dead batteries and no data collected. Some participants attempted to submit surveys after 
the fact for missed days, and some bracelets were damaged or lost all together. The low 
interest in participation from male participants limited the possibility of comparing the 
results based on gender.  Having a small group of total participants was the greatest 
limitation, and increasing the sample size would have provided more representative data 
to describe the relationship between motivation and walking for depressed persons.  This 
study suggests that mild depression should be addressed on an individual basis and that 
walking or wearing an activity monitor may benefit depression symptoms for some 
people but not others. 
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 Adding reminders or rewards for reaching specific goals – features supported 
already in new smartphones – might have improved compliance with the daily walking 
regimen, and thus enhance any effect of activity monitoring on depression. When this 
study began, more than two years ago, these features were not yet available. However, 
since the purchase of the UP bracelet, the market exploded with new trackers that include 
many features that could support walkers’ efforts to reach their goals. 
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CONCLUSION 
Minimal monitoring of daily activity for people suffering from mild depression is 
not enough to reduce symptoms related to depression.  Thus, wearing a basic activity 
tracker is insufficient motivation for depressed persons to increase their daily walking, 
but wearing trackers with more features might improve these outcomes.  Such additional 
features might include screens, activity reminders, or wireless connections to other 
devices (like tablets or televisions) that might enhance the motivational component in 
studies like this.  The new generation of trackers could have sent reminders to the 
participants’ other devices such as tablets or smartphones to help reduce missing 
information. 
The only significant result for Days on a question from the PHQ-9 involved 
question 5, related to appetite loss or overeating. Two other questions, 3 and 6, which 
dealt respectively with sleep and feeling bad about oneself yielded no significant results.  
The drastic fluctuation between scores over days successive suggests additional factors 
(e.g., procedural limitations, noted above) could have affected the results’ stability. 
For the majority of participants, their numbers of steps in a day were inversely 
related to their scores on the PHQ-9.  This suggested that the number of steps a person 
took per day may have had the effect of reducing depression symptom severity by the end 
of the day, compared to days where the same participants took fewer steps.  However, it 
might also reflect simply that people walked more when less depressed than they did on 
days when they are more depressed.  
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APPENDIX A: MODIFIED PHQ-9 QUESTIONNAIRE 
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APPENDIX B: TYPES OF DEPRESSION LISTED IN THE 
DSM 5 
In this section, the characteristics of each form of depression listed in the DSM 5’s 
chapter “Depressive Disorders” are summarized.  
 Disruptive Mood Disregulation is distinguished by frequent (three times or more 
per week) temper outbursts inconsistent with the individual’s level of development and 
includes verbal rages and physical aggression against people or property.  For example, 
tantrums may be common for toddlers, but when constantly performed by a neurotypical 
eight year old that child would possibly qualify for a diagnosis of Disruptive Mood 
Disregulation.  This diagnosis is generally reserved for children between the ages of 6 
and 10 years and must be demonstrated consistently (without a gap of 3+ months) for at 
least one year.  The core feature is severe, persistent irritability. 
 Major Depressive Disorder requires the presence of five or more symptoms for 
two consecutive weeks as well as either depressed mood or the loss of interest or 
pleasure.  The nine symptoms of which five must be present for diagnosis include: 
- Depressed mood 
 Markedly diminished interest or pleasure in almost all activities on most days 
- Significant weight loss or gain (5% of body weight in a month) when not dieting 
or intentionally gaining weight 
- Sleeping too much or too little (hypersomnia or insomnia, respectively) 
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-  Psychomotor agitation (restlessness) or retardation (sluggishness) observable by 
others; 
- Fatigue 
- Feelings of worthlessness or excessive/inappropriate guilt 
- Diminished ability to think or concentrate 
- Recurrent thoughts of death including suicide attempts, plans for committing 
suicide, and general suicide ideation without a plan. 
The individual must have never had a manic episode.  Documentation for this diagnosis 
on medical forms includes the level of depression (mild, moderate, or severe) and can 
denote when psychotic features are present. 
 Persistent Depressive Disorder consolidates chronic major depressive disorder 
and dysthymic disorder as defined in the DSM-IV.  It is a moderate but a persistent form 
of depression, which is present for at least two years in adults or one year in children. It 
must, along with depressed mood, include at least two or more of the following 
symptoms in the same two years without more than a 2 month gap at any interval:  poor 
appetite or overeating; insomnia or hypersomnia; fatigue; low self-esteem; poor 
concentration or indecision; feelings of hopelessness.  The lower threshold for number of 
symptoms and their persistence (two years rather than the minimum two weeks for Major 
Depressive Disorder) is what distinguishes Dysthymia from Major Depressive Disorder. 
 Premenstrual dysphoric disorder is a new addition to the DSM 5 classification 
after initially appearing in an appendix of DSM-IV only.  As its name indicated, it is only 
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specific to women. The authors of the DSM included it as a new diagnosis after 20 years 
of research indicating that its onset after ovulation and persists within few days of 
menstruation by distinctly affecting daily functioning.  The diagnosis requires a 
combination of five symptoms or more from two lists of symptoms.  Symptoms on the 
first list include mood swings, irritability, depression/hopelessness, and anxiety.  The 
second list includes decreased interest in usual activities, subjective difficulty 
concentrating, lethargy, changes in appetite including specific food cravings, 
hypersomnia or insomnia, a sensation of being overwhelmed, and physical symptoms 
such as weight gain, breast tenderness or swelling, joint or muscular pain, or a sensation 
of “bloating.”  Premenstrual dysphoric disorder differs from premenstrual syndrome as 
this latter has no requirement for number of symptoms. 
 The Substance/Medication-induced depressive disorder is a prominent and 
persistent disturbance of mood characterized by depressed mood or markedly diminished 
interest or pleasure in most if not all activities during or following substance intoxication 
or withdrawal, or exposure to a medication capable of producing the described 
symptoms.  This diagnosis is not appropriate if the depression precedes the exposure to 
the substance/medication or if the individual is not significantly distressed or impaired in 
their daily life. 
 An individual must have a history of another medical condition, which 
physiologically leads to depression to qualify for Depressive Disorder due to Another 
Medical Condition.  Medical conditions related can include stroke, Cushing’s disease, 
hypothyroidism, Huntington’s disease, Parkinson’s disease, and traumatic brain injury.  
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This diagnosis is not to be used if the depression is better explained by another mental 
disorder such as adjustment disorder with depressed mood. 
 Patients with symptoms characteristic of a depressive disorder but don’t qualify 
for any defined disorder are diagnosed as Other Specified Depressive Disorder.  This 
diagnosis is used if a patient reports significant distress or impairment in daily 
functioning and includes distinctions for 1) recurrent brief depression, 2) short-duration 
depressive episode (4-13 days), and 3) depressive episode with insufficient symptoms. 
 Unspecified Depressive Disorder is quite similar to Other Specified Depressive 
Disorder.  This diagnosis is selected if the clinician is unable to specify which depressive 
disorder their patient is expressing, and is intended for situations where there is not 
sufficient time for a behavioral evaluation such as in an emergency room. 
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